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Abstract
Background: The markers of inflammation and (apo)lipoproteins are associated with coro-
nary artery disease (CAD). Simultaneous assessment of the risk factors has been proposed to
improve the diagnosis of CAD. The aim of this study was to examine the potential interactions
between leukocyte counts and other risk factors.
Methods: The markers of inflammation, (apo)(lipo)proteins, (non)electrolytes, hematological
parameters and classical risk factors, were determined in 264 clinically stable angiographically
documented subjects. The subjects were classified as CAD cases or controls according to the
results of coronary angiography.
Results: The frequency and severity of CAD, Framingham CAD scores, relative and absolute
risk for CAD and the prevalence of diabetes mellitus and smoking were significantly higher in
the third relative to the first tertile of leukocyte counts. Subjects with leukocyte counts in the
upper tertile had significant higher levels of serum glucose, triglyceride, hsC-reactive protein,
potassium, phosphorus and measured osmolality, and lower levels of apoAI, total protein,
albumin and the ratio of albumin/globulins. Analyses by bivariate correlation on differential
leukocyte counts showed that these associations are carried mostly by neutrophil, except for
diabetes, glucose and triglyceride which were due to lymphocyte counts. By constructing dummy
combined variables, high leukocyte counts accompanied by smoking, hypertension, diabetes,
and high levels of serum glucose, cholesterol, apoB and apoB/apoAI ratio, exhibited amplified
high risk for CAD.
Conclusions: The results show that leukocyte count does interact multiplicatively with smok-
ing, hypertension, diabetes, glucose, cholesterol, apoB and apoB/AI ratio. The simultaneous
assessment of leukocyte counts and interactive risk factors enhances the diagnosis of CAD.
(Cardiol J 2011; 18, 3: 246–253)
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Introduction
It has been demonstrated that low grade inflam-
mation can contribute to vascular injury and athero-
sclerosis [1]. Inflammation also promotes atheroscle-
rotic plaque rupture and thrombosis [2]. The subject
has been meta-analyzed recently for high sensitivi-
ty C-reactive protein (hsCRP) and total and differ-
ential leukocyte counts [3, 4]. Several prospective
studies have indicated a consistent association be-
tween the total and differential leukocyte counts and
an increased risk for future cardiovascular events in
healthy individuals [5–10] and in acute coronary syn-
dromes [11–15] at baseline. But elevated leukocyte
counts have not been identified as a risk factor for
angina pectoris [16, 17]. Most of the associations
between leukocyte counts and cardiovascular events
is accounted for by neutrophil counts [18–24].
At practical approach, the levels of inflamma-
tory biomarkers are towards the upper limits of the
normal range in coronary artery disease (CAD) pa-
tients, and the differences between normal and CAD
groups are statistically (but not clinically) signifi-
cant [3, 4]. This problem limits the application of
inflammatory markers for clinical diagnosis. On the
other hand, the prognostic value may be much high-
er if it is combined with other risk factors such as
lipid parameters. Ridker et al. [25] and Rifai and Rid-
ker [26] have shown multiplicative interaction be-
tween four inflammatory markers with total choles-
terol [25, 26]. We have previously found that hsCRP
interacts with apoB, or the ratio of apoB/apoAI, bet-
ter than with cholesterol [27]. In this study, as part
of our previous work, we examined the relationship
between total and differential leukocyte counts and
more than 50 risk factors.
Methods
Experimental design, subjects and
angiographic assessment
The experimental design, angiographic assess-
ment and anthropometric measurements were as
described previously [27]. In brief, the study popu-
lation consisted of 138 men and 126 women aged
40–70 with suspected CAD who were consecutive-
ly referred and underwent their first coronary an-
giography at Zahra Hospital in the University of
Mazandaran. Those with a recent history of acute
myocardial infarction, percutaneous transluminal
coronary angioplasty, infectious or inflammatory
disease, severe liver or renal disease, neoplasm or
hematological disorders were excluded from our
study. Subjects with one or more lesions that nar-
rowed the lumen of any coronary artery significantly
(≥ 70%) were considered to be CAD cases. Those
with no narrowing formed the controls. The severi-
ty of coronary occlusion was scored on the basis of
the number and extent of lesions: 1 (normal),
2 (mild), 3 (moderate) and 4 (severe) [27].
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Biochemical and hematological
measurements
Blood sample collection, serum preparation and
the measurement of lipids, (apo)lipoproteins and
hsCRP are described in [28]. All measurements
were done on fresh serum except that of Lp(a), apo-
lipoproteins and hsCRP which were stored at –70°C
before analysis (for a maximum of three months).
All assays were performed blind. Serum Lp(a),
apoB100, apoAI and hsCRP were assayed by immu-
noturbidometric methods (DiaSys Diagnostics,
Holzheim, Germany) performed by the Pars-Azmon
company of Tehran. Assay performance was moni-
tored every 20 tests using the lipid control serums
Tru-Lab Lp(a), Tru-Lab Lipids and Tru-Lab CRP
(DiaSys Diagnostics). Lipid standards Tru Cal Lp(a),
apoB, apoAI and CRP were used to calibrate Cobas-
Mira Plus auto-analyzer (Roche Diagnostic Sys-
tems, Basle, Switzerland). All inter- and intra-as-
say coefficients of variance were less than 3% [27].
Serum total protein and albumin were measured by
biuret and bromocresol green (BCG) methods re-
spectively, using bovine serum albumin as protein
standard by LKB spectrophotometer (Biochrom
Ltd, Cambridge, UK). Serum proteins and lipopro-
teins were fractionated by electrophoresis on aga-
rose gels (Sebia, Evry, France) [27]. Serum osmo-
lality was measured by freezing-point depression
(Osmomat 030, Genotec, Berlin, Germany) [28].
White blood cells (WBC) were counted in whole
blood samples using a model T890 Coulter Counter
(Coulter, Miami, Florida, USA). Blood smears were
made from EDTA-treated samples and leukocyte
differential count was done manually. All other bio-
chemical and hematological parameters were mea-
sured by routine laboratory methods.
Statistical analyses
The results are presented as the means ± SD
and median (range) for normal and skewed distri-
buted variables respectively. Total leukocyte count
was categorized into tertiles based on the cut-off
points of the entire distribution, and the patients’
characteristics were calculated accordingly. Propor-
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tions and means (or median) for baseline risk fac-
tors were calculated. The significance of any differ-
ences in proportions or medians was tested with
Kruskal-Wallis test, and in means using analysis of
variance (ANOVA). All p-values are two-tailed and
differences were considered significant if p-values
were £ 0.05. The cut-off points were deduced from
receiver operating characteristic (ROC) analyses
and used to convert continuous variables into cate-
gorized binary states [28, 29]. A multivariate logis-
tic regression analysis was carried out to find out
the independency of correlation (SPSS version 10).
The results of multivariate analysis were expressed
as odds ratio with 95% confidence intervals. Biva-
riate correlation analysis was used to assess the cor-
relation between total and differential leukocyte
counts and other variables. In stratification analy-
sis, the study participants were classified into six
or nine groups according to leukocyte count tertiles
and tertiles of apoB, glucose, cholesterol or binary
state of smoking, diabetes mellitus (DM) and
hypertension. The relative odds were calculated by
cross-tabulation using c2-test. The Framingham
CAD risk scores (FCRS), and the relative and
absolute risks of CAD, were calculated according
to an algorithm based on a seven variables equa-
tion [30].
Results
Demographic and clinical
parameters of the subjects
The prevalence of DM, hypertension, cigarette
smoking and physical inactivity was higher in CAD
cases than in control subjects (Table 1). There were
no significant differences in the consumption of
hypolipidemic agents, b-adrenergic antagonists,
angiotensin-converting enzyme inhibitors, calcium
channel blockers or diuretics between the two
groups. A history of DM and medication by hypogly-
cemic agents and nitrates was commoner among
patients than controls.
Characteristics of the study participants
according to tertiles of total leukocyte count
The prevalence and severity of CAD, FCRS,
relative and absolute risk and odds ratios for CAD
were significantly associated with the tertiles of
total leukocyte count (Table 2). Cigarette smoking
and DM were more prevalent in the top than in the
bottom tertile of leukocyte count. Subjects with
leukocyte counts in the upper tertile had significant-
ly higher levels of serum hsCRP, glucose, triglyce-
rides, measured osmolality, potassium and phospho-
rus. The concentrations of serum apoAI, albumin,
Table 1. Demographic and clinical parameters in coronary artery disease (CAD) control and patient
groups.
Variables CAD control group CAD cases group P
Anthropometrics:
Age (year) 51.1 ± 10.3 57.0 ± 10.2 0.005
Gender (male/female) (41/61) (97/65) 0.005
BMI [kg/m2] 25.5 ± 3.2 26.3 ± 4.1 0.3
Physical inactivity 54 (52.9%) 105 (64.8%) 0.09
Smoking 6 (5.9%) 32 (20.0%) 0.005
Diabetes mellitus 13 (12.7%) 61 (37.7%) 0.0001
Hypertension 29 (28.4%) 67 (41.4%) 0.05
FH of premature CAD 28 (27.5%) 51 (31.5%) 0.7
PMH of diabetes mellitus 14 (13.7%) 52 (32.1%) 0.001
Drugs:
Antilipidemic 16 (15.7%) 42 (25.9%) 0.09
Hypoglycemic  5 (4.9%) 45 (27.8%) 0.0001
Nitrates  34 (33.3%) 85 (52.5%) 0.005
Beta-blocker 58 (56.9%) 90 (55.6%) 0.9
Calcium antagonists 7 (6.9.0%) 23 (14.2%) 0.09
ACE-inhibitors 8 (7.8%) 20 (12.3%) 0.3
Diuretics 2 (2.0%)  4 (2.5%) 0.8
The number of subjects in each group is shown in parenthesis. The significant differences between discontinuous variables were accessed by c2, and
continuous variables by t-student test; ACE — angiotensin-converting enzyme; BMI — body mass index; FH — family history; PMH — past medical
history
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total protein and the ratio of albumin/globulin de-
creased from the higher to the lower tertile.
Correlation of total and differential
leukocyte counts with other risk factors
Bivariate correlation analysis was performed to
address the correlations of leukocyte count and the
differential with other risk factors (Table 3). Leu-
kocyte count correlated with the prevalence of
smoking and DM positively and significantly. Leu-
kocyte counts correlated positively and significantly
with serum glucose, triglycerides, hsCRP, potassium,
and phosphorus, and negatively correlated with apoAI,
albumin, and the ratio of albumin/globulins. Most of
the associations of total leukocyte counts were car-
ried by neutrophils except that of the correlations
with smoking, DM, glucose, triglycerides and albu-
min which correlated more with lymphocytes.
Association of single or leukocyts
counts-combined variables with
coronary artery disease
Multivariate logistic regression analysis was
performed to test the possible interactions between
Table 2. Basic characteristics of the study population according to tertiles of leukocyte counts.
Variables Tertiles of leukocytes count [cell/nL] P
< 6.00 6.00–7.40 > 7.40
Anthropometrics:
CAD frequency  43 (51.2%)  50 (58.1%)  62 (68.9%) 0.03
CAD severity 1.2 ± 1.1 1.5 ± 1.2 1.8 ± 1.1 0.007
Framingham scores 6.7 ± 4.9 8.0 ± 4.8 8.3 ± 4.7 0.007
Relative risk 1.8 ± 1.1 2.2 ± 1.1 2.5 ± 1.4 0.004
Absolute risk 10.7 ± 8.1 11.9 ± 7.6 14.5 ± 9.9 0.001
Age (years) 55.8 ± 11.3 53.4 ± 10.6 55.6 ± 10.0 0.09
Male sex 41 (48.8%) 36 (41.9%) 53 (58.9%) 0.08
Physical inactivity 29 (34.5%) 38 (44.2%) 32 (35.6%) 0.4
Smoking 5 (6%) 15 (17.4%) 18 (20%) 0.02
Diabetes mellitus 18 (21.4%) 22 (25.6%) 33 (36.7%) 0.05
Hypertension 30 (35.7%) 38 (44.2%) 28 (31.1%) 0.3
Aspirin 37 (44.0%) 36 (41.9%) 39 (43.3%) 0.9
Biochemical and hematological parameters:
Leukocyte count [cell/nL] 5.2 ± 0.6 6.7 ± 0.4 8.9 ± 1.3 –
hsCRP [mg/L] 1.5 (0–18.5) 2.4 (0–20.1) 2.1 (0–115.1) 0.02
ESR [mm/h] 13 (2–50) 12 (4–45) 14 (2–49) 0.9
Glucose [mg/dL] 111.2 ± 39.8 119.9 ± 48.9 132.6 ± 64.3 0.02
Triglyceride [mg/dL] 140.5 (47–719) 170.5 (66–1426) 195 (40–1331) 0.005
Total cholesterol [mg/dL] 197.5 ± 47.5 206.2 ± 63.0 203.6 ± 53.1 0.6
HDL-cholesterol [mg/dL] 42.3 ± 13.2 39.0 ± 12.0 40.2 ± 10.8 0.2
LDL-cholesterol [mg/dL] 123.2 ± 45.5 128.4 ± 60.8 122.1 ± 46.7 0.7
apoB [mg/dL] 123.8 ± 30.5 130.8 ± 31.9 130.6 ± 26.9 0.2
apoAI [mg/dL] 137.9 ± 22.8 130.1 ± 20.5 132.4 ± 18.1 0.04
Lp(a) [mg/dL] 40.0 (7.0–270.0) 48.0 (4.0–290.0) 43.0 (4.0–280.0) 0.5
Albumin [g/dL] 5.02 ± 0.78 4.55 ± 0.66 4.67 ± 0.75 0.001
Total protein [g/dL] 9.25 ± 1.19 8.74 ± 1.08 9.04 ± 1.25 0.02
Albumin/globulin 1.20 ± 0.18 1.15 ± 0.19 1.12 ± 0.20 0.04
Measured osmolality [mOsm/kg H2O] 296.7 ± 6.2 297.2 ± 7.3 299.4 ± 9.7 0.05
Potassium [mEq/L] 4.3 ± 0.4 4.4 ± 0.4 4.6 ± 0.5 0.0001
Total calcium [mg/dL] 9.4 ± 0.9 8.9 ± 0.9 9.2 ± 1.1 0.4
Phosphorus [mg/dL] 3.9 ± 0.5 4.0 ± 0.6 4.1 ± 0.7 0.04
The subjects were divided into tertiles on the basis of leukocyte count distribution. The significance of any differences in means (or median) and
proportions were tested using analyses of variance and Kruskal-Wallis tests respectively; CAD — coronary artery disease; CRP — C-reactive protein;
ESR — erythrocyte sedimentation rate
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leukocyte counts and other risk factors with respect
to stable CAD (Table 4). Major classical risk fac-
tors, as well as apoB and Lp(a), were included in
the analysis. The criteria for variables entering into,
and removal from, multivariate regression equation
were 0.05 and 0.1 respectively. When single varia-
bles were entered into the multivariate analysis,
age, male sex, DM, hypertension, apoB, Lp(a), and
cholesterol remained in the model significantly
(Table 4, left column).
Dummy variables were constructed for the
combination of leukocyte counts and other risk fac-
tors. We tested all possible combinations of risk
factors, in particular for ones which apparently cor-
related with leukocyte counts according to the re-
sults of Tables 2 and 3. The data shows that leuko-
Table 3. The Pearson’s correlation coefficients (r) of leukocyte counts relative to other risk factors.
Bivariate correlation analysis was performed using SPSS software.
Correlation coefficients (r)
WBC Neutrophil Lymphocyte Monocyte Eoesinophil
CAD occurrence 0.147a 0.132a 0.076 0.022 0.117
CAD severity 0.166b 0.151b 0.082 0.029 0.134
Framingham score 0.097 0.006 0.136 0.006 0.045
Relative risk 0.168 0.128 0.149 0.086 0.018
Absolute risk 0.143 0.154 0.047 0.091 0.041
Smoking 0.162a 0.118a 0.165 –0.010 0.001
Diabetes mellitus 0.115a 0.091 0.116a 0.034 –0.025
Glucose 0.129a 0.088 0.150b 0.018 0.231
Triglycerides 0.150b 0.057 0.212b 0.062 –0.040
HDL-cholesterol –0.098 –0.116 –0.030 –0.055 –0.033
ApoAI –0.138 –0.135 –0.047 –0.040 –0.056
ApoB100 0.071 0.078 0.054 –0.036 –0.051
Lp(a) 0.021 –0.070 –0.040 –0.091 –0.010
hsCRP 0.209b 0.350c –0.096 0.059 –0.049
Albumin/globulin –0.185b –0.137a –0.169b –0.105 0.016
Albumin –0.192b –0.142a –0.171b –0.091 –0.005
Potassium 0.223c 0.240c 0.087 0.021 0.060
Total calcium –0.031 –0.022 –0.066 –0.036 0.063
Phosphate 0.096a 0.064 0.092 0.000 0.087
A, b and c indicate that the correlation coefficients are statistically significant at the confidence levels of p £ 0.05, p £ 0.005 and p £ 0.0001 respectively;
CAD — coronary artery disease; CRP — C-reactive protein; WBC — white blood cells
Table 4. Odds ratios for stable coronary artery disease according to the presence of single (left)
or leukocyte count-combined risk factors (right).
Single variables OR (95% CI) P Combined variables OR (95% CI) P
WBC 1.97 (1.15–3.38) 0.01
Male sex 3.31 (1.90–5.78) 0.001 Male sex/WBC 3.17 (1.59–6.35) 0.001
Hypertension 1.79 (1.01–3.16) 0.05 Hypertension/WBC 3.86 (1.55–9.59) 0.002
Diabetes mellitus 5.14 (2.47–10.70) 0.0001 Diabetes/WBC 5.22 (1.97–13.82) 0.0001
Smoking 3.87 (1.44–10.39) 0.004 Smoking/WBC 5.03 (1.47–17.23) 0.005
Cholesterol 2.10 (1.02–4.53) 0.05 Cholesterol/WBC 4.78 (1.39–16.43) 0.007
ApoB 2.72 (1.36–5.43) 0.005 ApoB/WBC 4.14 (1.98–8.65) 0.0001
Lp(a) 2.19 (1.14–4.23) 0.009 Lp(a)/WBC 3.77 (1.96–7.26) 0.0001
The following cut-off points were used to convert categorical variables into a binary state: leukocyte count: 6.75 × 109 cells/L; cholesterol: 240 mg/dL;
triglycerides: 200 mg/dL, apoB: 130 mg/dL, Lp(a): 30 mg/dL; and hsCRP: 3 mg/L; OR — odds ratio; CI — confidence interval; WBC — white blood cells
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Figure 1. Relative odds for coronary artery disease associated with tertiles of leukocyte count and presence/absence
of smoking, hypertension, diabetes and tertiles of glucose, apoB and apoB/AI ratio. The tertiles were < 94, 94–117,
> 117 mg/dL for glucose, < 116, 116–139, > 139 mg/dL for apoB and < 0.87, 0.87–1.05, > 1.05 for the ratio of apoB/AI.
In any figure, all groups were compared to the group with the lowest odds ratio; *, ** and *** indicate that the
corresponding value is significantly different from its respective control at the p £ 0.05, p £ 0.01 and p £ 0.001
confidence levels respectively; WBC — white blood cells.
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cyte counts exhibit multiplicative or synergistic
elevations in risk (additive in log scale) with hyper-
tension, smoking, apoB and cholesterol (Table 4,
right column). No such interactions were observed
with any other risk factors (results not shown).
To find out whether leukocyte counts added to
the predictive value of the major risk factors, the
study participants were stratified into six or nine
groups according to leukocyte counts tertiles and
binary state of smoking, hypertension, DM or ter-
tiles of glucose, cholesterol, apoB and apoB/apoAI
ratio (Fig. 1). The figures show that the relative
odds for CAD were lowest among the groups with
low leukocyte counts and low glucose, low apoB,
and low apoB/apoAI ratio, or in the absence of smok-
ing, hypertension and DM. In contrast, the relative
odds tended to be highest among groups with high
leukocyte counts and high glucose, apoB, apoB/apoAI
ratio or the presence of smoking, hypertension and
DM. The figures also show that the interactions be-
tween leukocyte counts and apoB are gradual, but
with glucose were revealed only in the top tertile,
i.e. in diabetic ranges.
Discussion
The results of the present study indicate that
the leukocyte counts had significant correlations
with the frequency and severity of CAD, FCRS,
relative and absolute risk for CAD. Leukocyte
counts also were correlates of smoking, DM, hy-
pertension, and the levels of serum glucose, apoB,
apoB/apoAI ratio, albumin, albumin/globulin ratio,
potassium and phosphate.
Several mechanisms have been postulated
whereby leukocyte counts might influence the de-
velopment of CAD [1, 2]. Leukocytes liberate pro-
teases, inflammatory mediators and radicals which
can cause proteolytic and oxidative damage to en-
dothelial cells. Abnormal leukocyte aggregation, and
adhesion and hypercoagulability and thrombosis
also might be involved [1, 2]. Leukocytes are stif-
fer and larger than other blood cells and may plug
the microvasculature. The associations of leuko-
cytes with other risk factors also may be important.
The correlation between leukocyte counts and
FCRS has been reported previously by Park et al. [6]
in a study of a healthy American population. Since
FCRS is calculated by the values of seven classical
risk factors [30], the association implies correlation
with some of them, especially smoking, hyperten-
sion, DM and cholesterol. The current results also
showed that the CAD risk accompanied by elevat-
ed total leukocyte count is carried mainly by in-
creased circulating neutrophils. This observation
agrees with most reports [18–24].
The association between leukocyte count and
frequency and severity of CAD has been depicted
by all prospective studies [5–15]. Although, all stud-
ies confirmed the association, debate continues re-
garding the independence of the correlation. Dia-
betes [31, 32], obesity [33, 34] and smoking [35, 36]
are the most important confounding risk factors. In
multivariate analysis of our data, the association of
leukocyte count with CAD weakened only if the
analysis was controlled for DM. A high frequency
of diabetic cases in our study might have increased
the power of DM to confound the correlation.
Several studies have shown the correlation of
inflammatory markers including hsCRP with glu-
cose levels or the presence of DM [31, 32]. Hyper-
glycemia is known to stimulate the release of in-
flammatory cytokines from various cell types and
can lead to the induction and secretion of acute-
-phase reactants by adipocytes [37]. But there is
limited data regarding the correlation of leukocyte
counts and glucose levels. The current results in-
dicate that serum glucose interacts with leukocyte
counts only in the top tertile, i.e. in the diabetic
range.
In the multimarker approach proposed by Rid-
ker et al. [25] and Rifai and Ridker [26], four inflam-
matory markers in combination with total choles-
terol are used to increase risk assessment for CAD.
In the previous report, we examined this approach
for the interaction between hsCRP and the ratio of
apoB/apoAI [38]. The present results show that the
leukocyte counts, in the same way as hsCRP, can
interact multiplicatively with the other risk factors
including apoB/apoAI ratio. Since the ratio of apoB/
/apoAI is known as the best markers of CAD [29],
simultaneous measurement of inflammatory mark-
ers in conjunction with apolipoproteins may be more
indicative than with cholesterol ratios. The mark-
ers of inflammation and metabolic syndrome (in-
cluding dyslipidemia) may therefore improve car-
diovascular stratification in patients with CAD.
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